Skip to content

Role of Ayurvedic Nutritional Supplement and Punarnavadi Mandoor in the management of Anaemia in adolescent girls

A cluster randomized study to evaluate the efficacy of Ayurveda Nutritional Supplement as an adjuvant to Punarnavadi Mandoor in the management of Moderate Iron Deficiency Anaemia in adolescent girls - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110056
Enrollment
540
Registered
2026-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D508- Other iron deficiency anemias

Interventions

None listed

Sponsors

Central Council For Research in Ayurvedic Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i. Adolescent girls aged 10 to 19 years with Moderate Anaemia (7 gm to 9.9gm) who are willing to take ayurvedic medications for 3 months

Exclusion criteria

Exclusion criteria: i. Adolescent girl with systemic illness, major gynecological disorders causing Anaemia like AUB, and taking medication like steroids, chemotherapy, Hormonal Treatment, immune-suppressants etc. ii. Participants with Vit B 12 deficiency (Below200pg/ml) iii. K/C/o bleeding disorder or severe or acute blood loss due to bleeding piles, episodes of epistasis, Hemoptysis, surgery, trauma iv. Altered Liver function (defined as AST and/or ALT greater than 2 times of the upper normal limit) and renal dysfunction (defined as S. creatinine greater than 1.2mg/dl) v. Adolescent girl having major co-morbidity like cardiac or pulmonary disorder vi. Any other condition that the Investigator thinks will jeopardise the Study

Design outcomes

Primary

MeasureTime frame
Change in the hemoglobin levelTimepoint: at baseline, 12th week

Secondary

MeasureTime frame
Change in the Proportion of participants with moderate Anaemia at the end of Intervention as compared to BaselineTimepoint: At baseline, 12th week;Change in score of FACIT Fatigue scaleTimepoint: At baseline, 12th week;iii.Change in VAS score of general weakness, dizziness, palpitationTimepoint: At baseline, 12th week;iv. Compliance scores reflecting adherence to interventionsTimepoint: 4th week, 8th week & 12th week

Countries

India

Contacts

Public ContactDr Ekta

Central Council for Research in Ayurvedic Sciences

dr.ektadogra@gmail.com7696863979

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026